Xeris Biopharma Holdings, Inc. (XERS) earnings
XERS earnings moved a median of -0.45% by the close. Quarterly and annual XERS reports and results, each read against the price at its own news timestamp. Back to the XERS overview →
29 measured XERS earnings events.
Where these XERS earnings landedvs 29 measured XERS earnings reactions
| Middle 50% of XERS earnings reactions | -2.94% to +2.24% |
|---|---|
| Median reaction (to close) | -0.45% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 XERS earnings events with a measured close landed between -2.94% and +2.24%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Xeris Biopharma Holdings For: Jun 30 | SEC filing · Form 10-Q | +2.09% | +6.73% | |
| Xeris Biopharma Reports Second Quarter 2026 Financial Results | Press release | +0.42% | +2.36% | |
| Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026 | Press release | +0.36% | +1.45% | |
| Form 10-Q Xeris Biopharma Holdings For: Mar 31 | SEC filing · Form 10-Q | -1.22% | -0.61% | |
| Xeris Biopharma Reports First Quarter 2026 Financial Results | Press release | -0.45% | -1.04% | |
| Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026 | Press release | -0.99% | -1.49% | |
| Form 10-K Xeris Biopharma Holdings For: Dec 31 | SEC filing · Form 10-K | +0.95% | +2.24% | |
| Form 10-Q Xeris Biopharma Holdings For: Sep 30 | SEC filing · Form 10-Q | +0.66% | -1.33% | |
| Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025 | Press release | -0.12% | -8.21% | |
| Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025 | Press release | +1.21% | +0.44% | |
| Form 10-Q Xeris Biopharma Holdings For: Jun 30 | SEC filing · Form 10-Q | +1.28% | +2.86% | |
| Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance | Press release | -5.15% | -2.94% | |
| Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025 | Press release | +1.17% | -0.78% | |
| Form 10-Q Xeris Biopharma Holdings For: Mar 31 | SEC filing · Form 10-Q | -0.96% | -3.47% | |
| Xeris Biopharma Reports Record First Quarter 2025 Financial Results | Press release | +2.26% | +16.74% | |
| Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025 | Press release | -3.06% | -2.18% | |
| Form 10-K Xeris Biopharma Holdings For: Dec 31 | SEC filing · Form 10-K | +1.21% | +2.17% | |
| Form 10-Q Xeris Biopharma Holdings For: Sep 30 | SEC filing · Form 10-Q | -4.40% | -3.81% | |
| Xeris Biopharma Reports Third Quarter 2024 Financial Results | Press release | -6.47% | +2.06% | |
| Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024 | Press release | -2.33% | +0.00% | |
| Form 10-Q Xeris Biopharma Holdings For: Jun 30 | SEC filing · Form 10-Q | +4.89% | +3.11% | |
| Xeris Biopharma Reports Second Quarter 2024 Financial Results | Press release | +1.36% | -0.45% | |
| Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024 | Press release | -1.03% | +5.14% | |
| Form 10-Q Xeris Biopharma Holdings For: Mar 31 | SEC filing · Form 10-Q | -1.83% | -7.85% | |
| Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events | Press release | -3.78% | +1.62% | |
| Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024 | Press release | +0.00% | +3.91% | |
| Form 10-K Xeris Biopharma Holdings For: Dec 31 | SEC filing · Form 10-K | -2.76% | -3.56% | |
| Form 10-Q Xeris Biopharma Holdings For: Sep 30 | SEC filing · Form 10-Q | -5.88% | -9.89% | |
| Xeris Biopharma Reports Third Quarter 2023 Financial Results | Press release | -7.25% | -12.80% |
Keep exploring
More XERS: analyst actions → · SEC filings → · XERS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | 256 | +0.04% | 57% |
| Prothena Corporation plc - Ordinary Shares (PRTA) | 256 | -0.04% | 49% |
| Cerus Corporation (CERS) | 255 | +0.09% | 52% |
| Avalon GloboCare Corp. (AVCO) | 254 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.